Methods Inf Med 2002; 41(03): 202-208
DOI: 10.1055/s-0038-1634435
Original Article
Schattauer GmbH

Changes regarding Age and Correlations between Serum Lipids and Body Mass Index in Humankind

K. Nagashima
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
I. Yamasawa
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
S. Kamohara
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
M. Shiota
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
T. Komori
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
Y. Watanabe
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
M. Nakano
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
T. Matsubara
1   Medicine and Health Sciences Institute, Tokyo Medical University, Tokyo, Japan
› Institutsangaben
Weitere Informationen


08. Februar 2018 (online)


Objectives: To improve insight into age and gender related distributions of serum lipids and their correlation with body mass index (BMI).

Methods: Serum lipids embracing atherogenic index (AI) and BMI were analyzed from the results obtained in 19,823 men and 14,788 women undergoing a health examination between 1986 and 1996.

Results: The changes in total cholesterol (TC), triglyceride (TG), AI and BMI differed regarding gender. Although high-density lipoprotein-cholesterol (HDL-C) showed a flat pattern for all ages in both genders, its level in women was higher than in men. The ratio of the number in the unsuitable range to those in the suitable range increased with age as to TC in both sexes, then more than half of the population have an unsuitable level in the sixth decade. As for the correlation between serum lipids and BMI: TC, TG and AI correlated positively, but HDL-C correlated negatively. There were significant gaps between both age and gender.

Conclusions: We suggest that the normal range of values of serum lipids needs to be revised according to gender and age to evaluate the risk status for a cardio-cerebrovascular disease more precisely in the field of preventive medicine. Simpler guidelines are preferable in specialized care as well as in general practice, particularly since computer technology is not yet universally adapted. In the near future, when computed information technology will be as common as the electricity and the telephone are current on the whole earth, all guidelines will have to be computed on the spot and personally.

  • References

  • 1 The Expert Panel.. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988; 148: 36-69.
  • 2 Study Group, European Atherosclerosis Society.. The recognition and management of hyperlipidemia in adults: A policy statement of the European Atherosclerosis Society. Eur Heart J 1988; 9: 571-600.
  • 3 Investigating Committee of Guideline for Diagnosis and Treatment of Hyperlipidemias, Japan Atherosclerosis Society.. Guideline for Diagnosis and Treatment of Hyperlipidemias in Adults. J Jpn Atheroscler Soc 1997; 25: 1-34.
  • 4 Japan society of Multiphasic Health Testing and Services.. The Health Encyclopedia of Human Dry Dock. Tokyo: Japan Broadcast Publishing; 1996
  • 5 Brown H, Gass G. Blood lipid and male sex hormone levels in a human population. Comp Biochem Physiol 1975; 51: 137-8.
  • 6 Calderon JR, Schneider R, Alexander C. et al. Stress, stress reduction and hypercholesterolemia in African Americans: A review. Ethn Dis 1999; 9: 451-62.
  • 7 Plavinski S, Plavinskaya S, Richter V. et al. The total and HDL-cholesterol levels in populations of St. Petersburg (Russia) and Leipzig (Germany). Nutr Metab Cardiovasc Dis 1999; 9: 184-91.
  • 8 Bennett P, Carroll D. Stress management approaches to the prevention of coronary heart disease. Brit J Clinical Psychology 1990; 29: 1-12.
  • 9 Ornish D, Scherwitz L, Doody R. et al. Effects of stress management training and dieteary changes in treating ischemic heart disease. JAMA 1983; 249: 54-9.
  • 10 Kaneko M, Oda N, Wada N, Okazaki I. The study of the relation between the working conditions and the prevalences of obesity, liver disorder and hyperlipidemia: Evaluation of physiological examination data during the terms of car manufacturing work and car sales work. J Occup Health 1995; 37: 33-41.
  • 11 Recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease.. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992; 2: 113-56.
  • 12 National Cholesterol Education Program.. Second Report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel). Circulation 1994; 89: 1329-445.
  • 13 Pyorala K, Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-31.
  • 14 Research Committee on Serum Lipid Level Survey 1990 in Japan.. Current state of and recent trends in serum lipid levels in the general Japanese population. J Atheroscler Thrombo 1996; 2: 122-32.
  • 15 Peters H, Westendorp I, Hak A. et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med 1999; 246: 521-8.
  • 16 Egusa G, Murakami F, Ito C. et al. Westernized food habits and concentrations of serum lipids in the Japanese. Atherosclerosis 1993; 100: 249-55.
  • 17 Long-Term Intervention with Pravastatine in Ischaemic Disease (LIPID) Study Group.. Prevention of cardiovascular events and death with paravastatine in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
  • 18 Hu F, Wang B, Chen C. et al. Body mass index and cardiovascular risk factors in a rural Chinese population. Am J Epidemiol 2000; 151: 88-97.
  • 19 Roo G, Stehouwer C, Meijer P. et al. both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women. A 2-year, placebo-controlled study. Arterioscler Thromb Vasc Biol 1999; 19: 2993-3000.
  • 20 Grundy S, Balady G, Criqui M. et al. Guide to primary prevention of cardiovascular diseases: A statement for healthcare professionals from the task force on risk reduction. Circulation 1997; 95: 2329-31.
  • 21 Stamler J, Stamler R, Neaton J. et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. JAMA 1999; 282: 2012-8.
  • 22 Ansell B, Watson K, Fogelman A. An evidence-based assessment of the NCEP adult treatment panel guidelines. JAMA 1999; 282: 2051-7.
  • 23 Rhoads G, Feinleib M. Serum triglyceride and risk of coronary heart disease, stroke, and total mortality in Japanese-American men. Arteriosclerosis 1983; 3: 316-22.
  • 24 Konishi M, Iida M, Naito Y. et al. Studies on the relationship between the trend of serum total cholesterol level and the incidence of cerebrocardio-vascular diseases based on the follow-up studies in Akita and Osaka with a special reference to the optimal serum total cholesterol level preventing both cerebral hemorrhage and coronary heart disease. J Jpn Atheroscler Soc 1987; 15: 1115-23.
  • 25 Lee J, Kawakubo K. A useful index highly correlated with coronary risk factors for community based obesity screening. Japanese Journal of Public Health 1999; 46 (Suppl. 02) 89-102.
  • 26 Tarui S. Hyperlipidemia and its complications in the Japanese. J Jpn Atheroscler Soc 1990; 18: 1-16.
  • 27 Nobmann E, Ebbesson S, White R, Bulkow L, Schraer C. Associations between dietary factors and plasma lipids related to cardiovascular disease among Siberian Yupiks of Alaska. Int J Circumpolar Health 1999; 58: 254-71.
  • 28 Serum-lipids in bushmen. Lancet 1968; 2 (7564) 395.
  • 29 Research Committee on Familial Hyperlipidemia in Japan.. Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Jpn Circ J 1983; 47: 1351-8.
  • 30 Eastwood M. Dietary fibre and serum-lipids. Lancet 1969; 7632: 1351-8.
  • 31 Morrison J, James F, Sprecher D, Khoury P, Daniels S. Sex and race differences in cardiovascular disease risk factor changes in school-children, 1975–1990: The Princeton School Study. Am J Public Health 1999; 89: 1708-14.
  • 32 Katzmarzyk P, Malina R, Bouchard C. Physical activity, physical fitness, and coronary heart disease risk factors in youth:The Quebec family study. Preventive Medicine 1999; 29: 555-62.
  • 33 Miller E, Appel L, Jiang L, Risby T. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96: 1097-101.